Hans-Ulrich Wittchen

Hans-Ulrich Wittchen

Top Cited Scholar 2023
Auto-generated profile, based on publicly available information

Hans-Ulrich Wittchen

Department of Psychiatry and Psychotherapy, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1994 in Archives of General Psychiatry
Verified
Journal Article
Closed access
PDF file
RKRonald C. Kessler
Ronald C. Kessler
KMKatherine A. McGonagle
Katherine A. McGonagle
SZShanyang Zhao
Shanyang Zhao
CNChristopher B. Nelson
Christopher B. Nelson
MHMichael Hughes
Michael Hughes
KKKenneth S. Kendler
Kenneth S. Kendler
Background: This study presents estimates of lifetime and 12-month prevalence of 14DSM-III-Rpsychiatric disorders from the National Comorbidity Survey, the first survey to administer a structured psychiatric interview to a national probability sample in the United States. Methods: TheDSM-III-Rpsychiatric disorders among persons aged 15 to 54 years in the noninstitutionalized civilian population of the United States were assessed with data collected by lay interviewers using a revised version of the Composite International Diagnostic Interview. Results: Nearly 50% of respondents reported at least one lifetime disorder, and close to 30% reported at least one 12-month disorder. The most common disorders were major depressive episode, alcohol dependence, social phobia, and simple phobia. More than half of all lifetime disorders occurred in the 14% of the population who had a history of three or more comorbid disorders. These highly comorbid people also included the vast majority of people with severe disorders. Less than 40% of those with a lifetime disorder had ever received professional treatment, and less than 20% of those with a recent disorder had been in treatment during the past 12 months. Consistent with previous risk factor research, it was found that women had elevated rates of affective disorders and anxiety disorders, that men had elevated rates of substance use disorders and antisocial personality disorder, and that most disorders declined with age and with higher socioeconomic status. Conclusions: The prevalence of psychiatric disorders is greater than previously thought to be the case. Furthermore, this morbidity is more highly concentrated than previously recognized in roughly one sixth of the population who have a history of three or more comorbid disorders. This suggests that the causes and consequences of high comorbidity should be the focus of research attention. The majority of people with psychiatric disorders fail to obtain professional treatment. Even among people with a lifetime history of three or more comorbid disorders, the proportion who ever obtain specialty sector mental health treatment is less than 50%. These results argue for the importance of more outreach and more research on barriers to professional help-seeking.

1 September 2011 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
HWH.U. Wittchen
H.U. Wittchen
FJF. Jacobi
F. Jacobi
JRJ. Rehm
J. Rehm
AGA. Gustavsson
A. Gustavsson
MSMikael Svensson
Mikael Svensson
HSH.-C. Steinhausen
H.-C. Steinhausen

1 August 2012 in International Journal of Methods in Psychiatric Research
Verified
Journal Article
Open access
PDF file
RKRonald C. Kessler
Ronald C. Kessler
MPMaria Petukhova
Maria Petukhova
NSNancy A. Sampson
Nancy A. Sampson
AZAlan M Zaslavsky
Alan M Zaslavsky
HWHans‐Ullrich Wittchen
Hans‐Ullrich Wittchen
Estimates of 12‐month and lifetime prevalence and of lifetime morbid risk (LMR) of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM‐IV‐TR) anxiety and mood disorders are presented based on US epidemiological surveys among people aged 13+. The presentation is designed for use in the upcoming DSM‐5 manual to provide more coherent estimates than would otherwise be available. Prevalence estimates are presented for the age groups proposed by DSM‐5 workgroups as the most useful to consider for policy planning purposes. The LMR/12‐month prevalence estimates ranked by frequency are as follows: major depressive episode: 29.9%/8.6%; specific phobia: 18.4/12.1%; social phobia: 13.0/7.4%; post‐traumatic stress disorder: 10.1/3.7%; generalized anxiety disorder: 9.0/2.0%; separation anxiety disorder: 8.7/1.2%; panic disorder: 6.8%/2.4%; bipolar disorder: 4.1/1.8%; agoraphobia: 3.7/1.7%; obsessive‐compulsive disorder: 2.7/1.2. Four broad patterns of results are most noteworthy: first, that the most common (lifetime prevalence/morbid risk) lifetime anxiety‐mood disorders in the United States are major depression (16.6/29.9%), specific phobia (15.6/18.4%), and social phobia (10.7/13.0%) and the least common are agoraphobia (2.5/3.7%) and obsessive‐compulsive disorder (2.3/2.7%); second, that the anxiety‐mood disorders with the earlier median ages‐of‐onset are phobias and separation anxiety disorder (ages 15–17) and those with the latest are panic disorder, major depression, and generalized anxiety disorder (ages 23–30); third, that LMR is considerably higher than lifetime prevalence for most anxiety‐mood disorders, although the magnitude of this difference is much higher for disorders with later than earlier ages‐of‐onset; and fourth, that the ratio of 12‐month to lifetime prevalence, roughly characterizing persistence, varies meaningfully in ways consistent with independent evidence about differential persistence of these disorders. Copyright © 2012 John Wiley & Sons, Ltd.

1 December 1988 in Archives of General Psychiatry
Verified
Journal Article
Closed access
PDF file
LRLee N. Robins
Lee N. Robins
JWJohn Wing
John Wing
HWHans Ulrich Wittchen
Hans Ulrich Wittchen
JHJohn E. Helzer
John E. Helzer
TBThomas F. Babor
Thomas F. Babor
LTLeland H. Towle
Leland H. Towle
• The Composite International Diagnostic Interview (CIDI), written at the request of the World Health Organization/US Alcohol, Drug Abuse, and Mental Health Administration Task Force on Psychiatric Assessment Instruments, combines questions from the Diagnostic Interview Schedule with questions designed to elicit Present State Examination items. It is fully structured to allow administration by lay interviewers and scoring of diagnoses by computer. A special Substance Abuse Module covers tobacco, alcohol, and other drug abuse in considerable detail, allowing the assessment of the quality and severity of dependence and its course. This article describes the design and development of the CIDI and the current field testing of a slightly reduced "core" version. The field test is being conducted in 19 centers around the world to assess the interviews' reliability and its acceptability to clinicians and the general populace in different cultures and to provide data on which to base revisions that may be found necessary. In addition, questions to assessInternational Classification of Diseases, ninth revision, and the revisedDSM-IIIdiagnoses are being written. If all goes well, the CIDI will allow investigators reliably to assess mental disorders according to the most widely accepted nomenclatures in many different populations and cultures.


1 October 2011 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
AGAnders Gustavsson
Anders Gustavsson
MSMikael Svensson
Mikael Svensson
FJFrank Jacobi
Frank Jacobi
CAChrister Allgulander
Christer Allgulander
JAJordi Alonso
Jordi Alonso
NONiels Jørgen Olesen
Niels Jørgen Olesen